Physician profile
Colton T Lambert
NPI 1477178697
$515.90
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $420 · 2023: $47.29 · 2024: $48.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $159.74 | 2022 | |
| Abbvie INC. | $122.22 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $43.27 | 2022 | |
| Dynavax Technologies Corporation | $39.11 | 2022 | |
| Merck Sharp & Dohme LLC | $33.65 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $31.08 | 2022 | |
| Lucid Diagnostics INC. | $25.95 | 2022 | |
| Gilead Sciences, INC. | $19.13 | 2022 | |
| Boston Scientific Corporation | $17.83 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.40 | 2022 | |
| Organon LLC | $10.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colton Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.